Tudor Investment Corp’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Hold |
900,000
| – | – | 0.02% | 610 |
|
|
2025
Q4 | $12.8M | Buy |
900,000
+731,016
| +433% | +$7.18M | 0.02% | 593 |
|
|
2025
Q3 | $1.33M | Buy |
168,984
+9,487
| +6% | +$67.5K | ﹤0.01% | 2070 |
|
|
2025
Q2 | $914K | Buy |
159,497
+88,206
| +124% | +$569K | ﹤0.01% | 2201 |
|
|
2025
Q1 | $582K | Sell |
71,291
-77,577
| -52% | -$718K | ﹤0.01% | 2190 |
|
|
2024
Q4 | $1.4M | Buy |
148,868
+514
| +0.3% | +$5.34K | 0.01% | 1489 |
|
|
2024
Q3 | $1.58M | Buy |
+148,354
| New | +$1.62M | 0.01% | 1344 |
|
|
2023
Q2 | – | Sell |
-133,697
| Closed | -$1.48M | – | 2606 |
|
|
2023
Q1 | $1.48M | Buy |
133,697
+79,120
| +145% | +$975K | 0.02% | 962 |
|
|
2022
Q4 | $666K | Buy |
+54,577
| New | +$614K | 0.01% | 1400 |
|
|
2021
Q4 | – | Sell |
-12,579
| Closed | -$120K | – | 2611 |
|
|
2021
Q3 | $120K | Buy |
+12,579
| New | +$129K | ﹤0.01% | 2353 |
|
|
2021
Q2 | – | Sell |
-63,292
| Closed | -$625K | – | 1699 |
|
|
2021
Q1 | $625K | Buy |
63,292
+17,150
| +37% | +$265K | 0.01% | 1050 |
|
|
2020
Q4 | $1.06M | Buy |
46,142
+30,546
| +196% | +$625K | 0.03% | 675 |
|
|
2020
Q3 | $220K | Buy |
+15,596
| New | +$227K | 0.01% | 1114 |
|
|
2020
Q1 | – | Sell |
-49,156
| Closed | -$479K | – | 1144 |
|
|
2019
Q4 | $479K | Buy |
49,156
+18,851
| +62% | +$173K | 0.02% | 733 |
|
|
2019
Q3 | $243K | Sell |
30,305
-186,971
| -86% | -$2.03M | 0.01% | 914 |
|
|
2019
Q2 | $2.71M | Buy |
+217,276
| New | +$2.76M | 0.08% | 230 |
|
|
2019
Q1 | – | Sell |
-79,495
| Closed | -$762K | – | 1149 |
|
|
2018
Q4 | $762K | Buy |
79,495
+42,898
| +117% | +$472K | 0.02% | 480 |
|
|
2018
Q3 | $442K | Sell |
36,597
-6,127
| -14% | -$85.7K | 0.01% | 726 |
|
|
2018
Q2 | $667K | Buy |
+42,724
| New | +$646K | 0.02% | 580 |
|
|
2017
Q3 | – | Sell |
-12,332
| Closed | -$124K | – | 1144 |
|
|
2017
Q2 | $124K | Buy |
+12,332
| New | +$99.2K | ﹤0.01% | 947 |
|
|
2017
Q1 | – | Sell |
-51,290
| Closed | -$255K | – | 1431 |
|
|
2016
Q4 | $255K | Buy |
+51,290
| New | +$355K | 0.01% | 1093 |
|
|
2016
Q3 | – | Sell |
-72,981
| Closed | -$398K | – | 1524 |
|
|
2016
Q2 | $398K | Buy |
72,981
+56,031
| +331% | +$392K | 0.01% | 998 |
|
|
2016
Q1 | $143K | Buy |
+16,950
| New | +$120K | ﹤0.01% | 1569 |
|
|
2015
Q4 | – | Sell |
-38,735
| Closed | -$542K | – | 1705 |
|
|
2015
Q3 | $542K | Sell |
38,735
-67,621
| -64% | -$1.06M | 0.02% | 730 |
|
|
2015
Q2 | $1.5M | Buy |
106,356
+94,736
| +815% | +$1.14M | 0.04% | 274 |
|
|
2015
Q1 | $126K | Sell |
11,620
-86,902
| -88% | -$766K | ﹤0.01% | 1360 |
|
|
2014
Q4 | $820K | Buy |
98,522
+20,443
| +26% | +$140K | 0.03% | 450 |
|
|
2014
Q3 | $465K | Buy |
+78,079
| New | +$409K | 0.02% | 723 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Tudor Investment Corp's FOLD Position: Q1 2026 in Review
Tudor Investment Corp held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 900,000 shares worth $13M. The position accounts for 0.02% of the portfolio, ranked #610.
Tudor Investment Corp first reported a position in FOLD in Q3 2014 and has held it in 28 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Tudor Investment Corp held 900,000 shares of Amicus Therapeutics worth $13M as of Q1 2026.
- Tudor Investment Corp left its Amicus Therapeutics share count unchanged in Q1 2026.
- Amicus Therapeutics made up 0.02% of Tudor Investment Corp's portfolio in Q1 2026, its #610 holding.
- Tudor Investment Corp first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 28 quarters since.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.